argenx (NasdaqGS:ARGX) Update / Briefing September 16, 2025 02:00 PM ET Company ParticipantsBeth DelGiacco - VP - Corporate Communications & IRRoeland Vanhauwaert - Senior ScientistPeter Ulrichts - Chief Scientific OfficerSteven Burden - Senior Lecturer - NeurologyLuc Truyen - Chief Medical OfficerRebecca Shilling - Senior Medical DirectorJeff Guptill - Disease Area Development Lead - Neuromuscular, Clinical DevelopmentRicardo Maselli - professor - NeuroscienceTim Van Hauwermeiren - Co-Founder, CEO & Direct ...